LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Затворен

1.81 8.38

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.62

Максимум

1.84

Ключови измерители

By Trading Economics

Приходи

-9.3M

-16M

EPS

-0.51

Служители

31

EBITDA

-9.3M

-17M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+255.03% upside

Дивиденти

By Dow Jones

Следващи печалби

1.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

2.2M

51M

Предишно отваряне

-6.57

Предишно затваряне

1.81

Actinium Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom 2Q Sales Climb on Booming AI Demand

5.06.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5.06.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Edges Higher on Weak U.S. Data -- Market Talk

5.06.2025 г., 23:30 ч. UTC

Пазарно говорене

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5.06.2025 г., 21:32 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:24 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Rev $15B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Net $4.97B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Adj EPS $1.58 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom Sees 3Q Rev $15.8B >AVGO

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5.06.2025 г., 19:22 ч. UTC

Пазарно говорене

Oil Futures Resume Upward Moves -- Market Talk

5.06.2025 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5.06.2025 г., 18:32 ч. UTC

Пазарно говорене

Gold Slips After Trump-Xi Call -- Market Talk

5.06.2025 г., 18:26 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5.06.2025 г., 18:06 ч. UTC

Пазарно говорене

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5.06.2025 г., 16:30 ч. UTC

Придобивния, сливания и поглъщания

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 16:18 ч. UTC

Пазарно говорене

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5.06.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5.06.2025 г., 16:03 ч. UTC

Пазарно говорене

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5.06.2025 г., 15:49 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Actinium Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

255.03% нагоре

12-месечна прогноза

Среден 6 USD  255.03%

Висок 9 USD

Нисък 4 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Actinium Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.